Cardiovascular adverse effects of lopinavir/ritonavir and hydroxychloroquine in COVID-19 patients: Cases from a single pharmacovigilance centre

por Istampoulouoglou, Ioanna, Zimmermanns, Barbara, Grandinetti, Tanja, Marzolini, Catia, Harings-Kaim, Annette, Koechlin-Lemke, Sarah, Scholz, Irene, Bassetti, Stefano, Leuppi-Taegtmeyer, Anne B
Publicado 2021